US4814178A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Floating sustained release therapeutic compositions
Assignee: Individual
•
Filing: 1987-07-01
•
Granted: 1989-03-21
•
Expires: 2007-07-01
Abstract
Abstract Non-compressed sustained release tablets which will float on gastric fulid are described. The tablets comprise a hydrocolloid gelling agent, the selected therapeutic agent and water.
Inventors
- 👤 Sanford Bolton
- 👤 Philip H. Izevbehai
- 👤 Subhash Desai
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 23:33
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0065; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/52; A61K9/20; A61K9/2004; A61K9/2022; A61K9/205
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
99 words
A therapeutic composition in unit dosage form as a non-compressed tablet having a network of multitudinous air holes and passages therein and a density of less than one and capable of floating on gastric fluid in vivo and providing sustained release of the therapeutic agent over an extended period of time, comprising a matrix formed from a gelling agent, a therapeutic agent and water, characterized in that, in percentages by weight based on the total weight of the tablet, the latter contains 2 to 6.5% gelling agent, 75 to 92.5% therapeutic agent, 0% oil and the balance is water.
Claim 2
Dependent Claim
99 words
A therapeutic composition in unit dosage form as a non-compressed tablet having a network of multitudinous air holes and passages therein and a density of less than one and capable of floating on gastric fluid in vivo and providing sustained release of the therapeutic agent over an extended period of time, comprising a matrix formed from a gelling agent, a therapeutic agent and water, characterized in that, in percentages by weight based on the total weight of the tablet, the latter contains 2 to 6.5% gelling agent, 75 to 92.5% therapeutic agent, 0% oil and the balance is water.
Claim 3
Dependent Claim
39 words
The composition according to claim 1 in which the gelling agent is one or more agents selected from the group consisting of agar, agarose and a mixture of locust bean gum with either agar, agarose, alginic acid and carrageenan.
Claim 4
Dependent Claim
96 words
A therapeutic composition in unit dosage form as a non-compressed tablet having a network of multitudinous air holes and passages therein and a density of less than one and capable of floating on gastric fluid in vivo and providing sustained release of the therapeutic agent over an extended period of time, comprising a matrix formed from a gelling agent, theophylline and water, characterized in that, in percentages by weight based on the total weight of the tablet, the latter contains 2 to 6.5% gelling agent, 75 to 92.5% theophylline, 0% oil and the balance is water.
Claim 5
Dependent Claim
96 words
A therapeutic composition in unit dosage form as a non-compressed tablet having a network of multitudinous air holes and passages therein and a density of less than one and capable of floating on gastric fluid in vivo and providing sustained release of the therapeutic agent over an extended period of time, comprising a matrix formed from a gelling agent, theophylline and water, characterized in that, in percentages by weight based on the total weight of the tablet, the latter contains 2 to 6.5% gelling agent, 75 to 92.5% theophylline, 0% oil and the balance is water.
Claim 6
Dependent Claim
39 words
The composition according to claim 3 in which the gelling agent is one or more agents selected from the group consisting of agar, agarose and a mixture of locust bean gum with either agar, agarose, alginic acid and carrageenan.
Claim 7
Independent Claim
137 words
A method of forming a non-compressed tablet having a network of multitudinous air holes and passages therein and a density of less than one and capable of floating on gastric fluid in vivo and providing sustained release of the therapeutic agent over an extended period of time, which comprises forming a solution of gelling agent in water, cooling said solution but not to the point where gelation takes place, adding a therapeutic agent with stirring, pouring the resultant suspension into a tablet mold and letting it stand in the mold to form a gel, and drying the molded gel tablets to reduce the water content, characterized in that the aqueous solution contains 0.5 to 4% gelling agent, 25 to 40% therapeutic agent, 0% oil and the balance is water, all by weight based on the total weight.
Claim 8
Independent Claim
137 words
A method of forming a non-compressed tablet having a network of multitudinous air holes and passages therein and a density of less than one and capable of floating on gastric fluid in vivo and providing sustained release of the therapeutic agent over an extended period of time, which comprises forming a solution of gelling agent in water, cooling said solution but not to the point where gelation takes place, adding a therapeutic agent with stirring, pouring the resultant suspension into a tablet mold and letting it stand in the mold to form a gel, and drying the molded gel tablets to reduce the water content, characterized in that the aqueous solution contains 0.5 to 4% gelling agent, 25 to 40% therapeutic agent, 0% oil and the balance is water, all by weight based on the total weight.
Claim 9
Dependent Claim
39 words
A method according to claim 5 in which the gelling agent is one or more agents selected from the group consisting of agar, agarose and a mixture of locust bean gum with either agar, agarose, alginic acid and carrageenan.
Claim 10
Dependent Claim
13 words
A method according to claim 5 in which the therapeutic agent is theophylline.
References Cited (Backward Citations)
US2704269A
Cited
US3065143A
Cited
US3445242A
Cited
US3574820A
Cited
US3900577A
Cited
US3939001A
Cited
US3976764A
Cited
US4064282A
Cited
US4126672A
Cited
US4140755A
Cited
US4167558A
Cited
US4055178A
Cited
US4434153A
Cited
US4451260A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-03-20 | 1992-09-19 | 1993-03-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-03-20 | 1996-09-19 | 1997-03-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-03-20 | 2000-09-19 | 2001-03-21 | $7700.00 | Window Closed / Lapsed |